PTSD Mobile App

PTSD Mobile App for Cancer Survivors

What will happen during the trial?

The purpose of this study is to use a stepped-care approach in treating symptoms of posttraumatic stress disorder (PTSD). The information learned by doing this study may help us to develop some target treatments for PTSD symptoms in survivors of stem cell transplant.

Participants in this study will be randomized to a mobile app or usual care. An assessment will be made after 4 weeks and a determination made of adding more intensive treatment. Participants will be asked to complete a questionnaire 4 times over a period of 6 months, at the time your participation is complete.

More Information

Trial Status
Accepting patients
Trial Phase
Observational Trial
Enrollment
400 patients (estimated)
Sponsors
Duke Cancer Center
Tags
Allogeneic Stem Cell Transplant, Autologous Stem Cell Transplant, Post-Allogeneic Stem Cell Transplant, Post-Autologous Stem Cell Transplant
Trial Type
Supportive
Last Update
1 week ago
SparkCures ID
1262
NCT Identifier
NCT04058795

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print a patient-friendly report to share with your patient.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.